About this trial
This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Thyroidectomy or bilateral thyroid resection of any indication
Written informed consent obtained after detailed patient information and provision of an information sheet
Disqualifiers
Age ≤ 18 years
Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)
Previous surgery in the neck region
Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Active vitamin D
- Calcium
Treatment groups
Sponsors and collaborators
Nicolas Schlegel
Lead sponsor
University of Wuerzburg
Sponsor institution
University of Wuerzburg
Collaborator